Total Payments
$8,904
2024 Payments
$50.00
Companies
34
Transactions
414
Medicare Patients
3,316
Medicare Billing
$349,798
Payment Breakdown by Category
Food & Beverage$6,778 (76.1%)
Travel$1,324 (14.9%)
Research$627.05 (7.0%)
Education$175.10 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,778 | 397 | 76.1% |
| Travel and Lodging | $1,324 | 3 | 14.9% |
| Unspecified | $627.05 | 8 | 7.0% |
| Education | $175.10 | 6 | 2.0% |
Payments by Type
General
$8,277
406 transactions
Research
$627.05
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Theravance Biopharma Inc. | $1,630 | 5 | $0 (2017) |
| GlaxoSmithKline, LLC. | $1,400 | 65 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,093 | 72 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $898.63 | 47 | $0 (2023) |
| Grifols USA, LLC | $417.13 | 28 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $411.14 | 20 | $0 (2022) |
| Insmed, Inc. | $305.45 | 15 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $272.19 | 14 | $0 (2023) |
| Electromed, Inc. | $260.61 | 26 | $0 (2023) |
| Mylan Specialty L.P. | $220.23 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.00 | 1 | Novo Nordisk Inc ($50.00) |
| 2023 | $539.23 | 26 | AstraZeneca Pharmaceuticals LP ($136.61) |
| 2022 | $1,089 | 70 | GlaxoSmithKline, LLC. ($154.13) |
| 2021 | $1,345 | 83 | Boehringer Ingelheim Pharmaceuticals, Inc. ($216.92) |
| 2020 | $1,333 | 47 | GlaxoSmithKline, LLC. ($650.43) |
| 2019 | $1,029 | 65 | Boehringer Ingelheim Pharmaceuticals, Inc. ($248.46) |
| 2018 | $782.18 | 53 | AstraZeneca Pharmaceuticals LP ($179.28) |
| 2017 | $2,737 | 69 | Theravance Biopharma Inc. ($1,630) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Obesity | ||||||
| 10/10/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Pulmonology | ||||||
| 10/10/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: HFCWO | ||||||
| 08/30/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $8.91 | General |
| Category: HFCWO | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $84.01 | General |
| Category: Respiratory | ||||||
| 07/19/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.11 | General |
| Category: HFCWO | ||||||
| 06/27/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: HFCWO | ||||||
| 06/12/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $6.87 | General |
| Category: HFCWO | ||||||
| 05/17/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/11/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: HFCWO | ||||||
| 05/03/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/24/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: SLEEP MEDICINE | ||||||
| 04/19/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Pulmonology | ||||||
| 04/11/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: HFCWO | ||||||
| 04/05/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Respiratory | ||||||
| 03/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/14/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Inflammation | ||||||
| 03/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiology | ||||||
| 02/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Respiratory | ||||||
| 01/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONT | GlaxoSmithKline, LLC. | $627.05 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 708 | 961 | $174,524 | $75,554 |
| 2022 | 15 | 936 | 1,236 | $235,842 | $105,252 |
| 2021 | 14 | 856 | 1,120 | $226,831 | $102,031 |
| 2020 | 16 | 816 | 1,033 | $167,305 | $66,960 |
Total Patients
3,316
Total Services
4,350
Medicare Billing
$349,798
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 378 | $49,896 | $31,769 | 63.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 41 | 43 | $59,125 | $19,031 | 32.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 18 | 18 | $19,404 | $7,802 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 59 | $5,841 | $3,096 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 24 | $3,960 | $2,907 | 73.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $5,049 | $2,898 | 57.4% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 101 | 174 | $5,742 | $1,825 | 31.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 45 | 45 | $7,425 | $1,777 | 23.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 42 | 42 | $5,082 | $1,304 | 25.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 45 | 45 | $5,445 | $1,214 | 22.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 56 | 57 | $3,010 | $890.53 | 29.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 32 | 33 | $3,993 | $815.04 | 20.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 16 | $552.00 | $224.96 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 343 | $45,276 | $31,705 | 70.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 61 | 62 | $85,250 | $28,295 | 33.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 29 | 29 | $31,262 | $12,974 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 158 | $15,642 | $8,153 | 52.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 61 | $10,065 | $7,652 | 76.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $8,602 | $5,050 | 58.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 105 | 143 | $7,550 | $2,590 | 34.3% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 98 | 159 | $5,247 | $1,929 | 36.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 43 | 43 | $7,095 | $1,720 | 24.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 43 | 43 | $5,203 | $1,335 | 25.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 43 | 43 | $5,203 | $1,189 | 22.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 43 | 45 | $5,445 | $1,104 | 20.3% |
About Dr. Gowdhami Mohan, MD
Dr. Gowdhami Mohan, MD is a Internal Medicine healthcare provider based in Clarksdale, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114921806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gowdhami Mohan, MD has received a total of $8,904 in payments from pharmaceutical and medical device companies, with $50.00 received in 2024. These payments were reported across 414 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,778).
As a Medicare-enrolled provider, Mohan has provided services to 3,316 Medicare beneficiaries, totaling 4,350 services with total Medicare billing of $349,798. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Clarksdale, MS
- Active Since 06/09/2005
- Last Updated 08/07/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114921806
Products in Payments
- NUCALA (Biological) $710.78
- OFEV (Drug) $674.82
- Prolastin-C Liquid (Biological) $393.97
- TRELEGY ELLIPTA (Drug) $385.61
- GLASSIA (Biological) $336.37
- Arikayce (Drug) $305.45
- SYMBICORT (Drug) $270.68
- SMARTVEST (Device) $260.61
- ANORO (Drug) $180.28
- Xyrem (Drug) $174.81
- STIOLTO RESPIMAT (Drug) $167.84
- Wakix (Drug) $150.69
- BREZTRI (Drug) $142.58
- FASENRA (Drug) $138.16
- NUZYRA (Drug) $126.93
- DUPIXENT (Biological) $125.33
- BEVESPI AEROSPHERE (Drug) $122.27
- TEZSPIRE (Biological) $117.46
- Yupelri (Drug) $116.38
- BREO (Drug) $112.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.